Loading…
This entity appears on both sides of lobbying disclosures. The firm tab shows registrant-reported income; the client tab shows client-reported lobbying spend. Contract awards are separate and are not included here.
Lobbying Spend
$2.9M
Filings
92
Firms Hired
3
Active Period
2013–2026
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Ensuring Patient Access to Critical Breakthrough Products Act
2026 · third_quarter · Firm: WILLIAMS AND JENSEN, PLLC
Breakthrough pathway bill (H.R. 5343, S. 1717), CMS reimbursement of medical devices generally, and FDA issues related to medical devices.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 5343
Ensuring Patient Access to Critical Breakthrough Products Act
2026 · third_quarter · Firm: WILLIAMS AND JENSEN, PLLC
Breakthrough pathway bill (H.R. 5343, S. 1717), CMS reimbursement of medical devices generally, and FDA issues related to medical devices. CMS RAPID Proposed Rule.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 5343
Ensuring Patient Access to Critical Breakthrough Products Act of 2025
2026 · third_quarter · Firm: WILLIAMS AND JENSEN, PLLC
Breakthrough pathway bill (H.R. 5343, S. 1717), CMS reimbursement of medical devices generally, and FDA issues related to medical devices. CMS RAPID Proposed Rule.
Client expense: — · Firm income: $60,000
Matched citations: S. 1717
Ensuring Patient Access to Critical Breakthrough Products Act of 2025
2026 · third_quarter · Firm: WILLIAMS AND JENSEN, PLLC
Breakthrough pathway bill (H.R. 5343, S. 1717), CMS reimbursement of medical devices generally, and FDA issues related to medical devices.
Client expense: — · Firm income: $60,000
Matched citations: S. 1717
Ensuring Patient Access to Critical Breakthrough Products Act
2026 · third_quarter · Firm: NOVOCURE INC.
General Medicare Issues. H.R.5343/S.1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025.
Client expense: $160,000 · Firm income: —
Matched citations: H.R.5343
Ensuring Patient Access to Critical Breakthrough Products Act of 2025
2026 · third_quarter · Firm: NOVOCURE INC.
General Medicare Issues. H.R.5343/S.1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025.
Client expense: $160,000 · Firm income: —
Matched citations: S.1717
Ensuring Patient Access to Critical Breakthrough Products Act
2026 · second_quarter · Firm: WILLIAMS AND JENSEN, PLLC
Breakthrough pathway bill (H.R. 5343, S. 1717), CMS reimbursement of medical devices generally, and FDA issues related to medical devices.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 5343
Ensuring Patient Access to Critical Breakthrough Products Act
2026 · second_quarter · Firm: WILLIAMS AND JENSEN, PLLC
Breakthrough pathway bill (H.R. 5343, S. 1717), CMS reimbursement of medical devices generally, and FDA issues related to medical devices.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 5343
Ensuring Patient Access to Critical Breakthrough Products Act of 2025
2026 · second_quarter · Firm: WILLIAMS AND JENSEN, PLLC
Breakthrough pathway bill (H.R. 5343, S. 1717), CMS reimbursement of medical devices generally, and FDA issues related to medical devices.
Client expense: — · Firm income: $60,000
Matched citations: S. 1717
Ensuring Patient Access to Critical Breakthrough Products Act of 2025
2026 · second_quarter · Firm: WILLIAMS AND JENSEN, PLLC
Breakthrough pathway bill (H.R. 5343, S. 1717), CMS reimbursement of medical devices generally, and FDA issues related to medical devices.
Client expense: — · Firm income: $60,000
Matched citations: S. 1717
Ensuring Patient Access to Critical Breakthrough Products Act
2026 · second_quarter · Firm: NOVOCURE INC.
General Medicare Issues. H.R.5343/S.1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025.
Client expense: $160,000 · Firm income: —
Matched citations: H.R.5343
Ensuring Patient Access to Critical Breakthrough Products Act of 2025
2026 · second_quarter · Firm: NOVOCURE INC.
General Medicare Issues. H.R.5343/S.1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025.
Client expense: $160,000 · Firm income: —
Matched citations: S.1717
Ensuring Patient Access to Critical Breakthrough Products Act
2026 · first_quarter · Firm: WILLIAMS AND JENSEN, PLLC
Breakthrough pathway bill (H.R. 5343, S. 1717), CMS reimbursement of medical devices generally, and FDA issues related to medical devices.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 5343
Ensuring Patient Access to Critical Breakthrough Products Act
2026 · first_quarter · Firm: WILLIAMS AND JENSEN, PLLC
Breakthrough pathway bill (H.R. 5343, S. 1717), CMS reimbursement of medical devices generally, and FDA issues related to medical devices.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 5343
Ensuring Patient Access to Critical Breakthrough Products Act of 2025
2026 · first_quarter · Firm: WILLIAMS AND JENSEN, PLLC
Breakthrough pathway bill (H.R. 5343, S. 1717), CMS reimbursement of medical devices generally, and FDA issues related to medical devices.
Client expense: — · Firm income: $60,000
Matched citations: S. 1717
Ensuring Patient Access to Critical Breakthrough Products Act of 2025
2026 · first_quarter · Firm: WILLIAMS AND JENSEN, PLLC
Breakthrough pathway bill (H.R. 5343, S. 1717), CMS reimbursement of medical devices generally, and FDA issues related to medical devices.
Client expense: — · Firm income: $60,000
Matched citations: S. 1717
Ensuring Patient Access to Critical Breakthrough Products Act
2026 · first_quarter · Firm: NOVOCURE INC.
General Medicare Issues. H.R.5343/S.1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025.
Client expense: $180,000 · Firm income: —
Matched citations: H.R.5343
Ensuring Patient Access to Critical Breakthrough Products Act of 2025
2026 · first_quarter · Firm: NOVOCURE INC.
General Medicare Issues. H.R.5343/S.1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025.
Client expense: $180,000 · Firm income: —
Matched citations: S.1717
Ensuring Patient Access to Critical Breakthrough Products Act
2025 · fourth_quarter · Firm: WILLIAMS AND JENSEN, PLLC
Breakthrough pathway bill (H.R. 5343, S. 1717), CMS reimbursement of medical devices generally, and FDA issues related to medical devices.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 5343
Ensuring Patient Access to Critical Breakthrough Products Act
2025 · fourth_quarter · Firm: WILLIAMS AND JENSEN, PLLC
Breakthrough pathway bill (H.R. 5343, S. 1717), CMS reimbursement of medical devices generally, and FDA issues related to medical devices.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 5343
Ensuring Patient Access to Critical Breakthrough Products Act of 2025
2025 · fourth_quarter · Firm: WILLIAMS AND JENSEN, PLLC
Breakthrough pathway bill (H.R. 5343, S. 1717), CMS reimbursement of medical devices generally, and FDA issues related to medical devices.
Client expense: — · Firm income: $60,000
Matched citations: S. 1717
Ensuring Patient Access to Critical Breakthrough Products Act of 2025
2025 · fourth_quarter · Firm: WILLIAMS AND JENSEN, PLLC
Breakthrough pathway bill (H.R. 5343, S. 1717), CMS reimbursement of medical devices generally, and FDA issues related to medical devices.
Client expense: — · Firm income: $60,000
Matched citations: S. 1717
Ensuring Patient Access to Critical Breakthrough Products Act
2025 · fourth_quarter · Firm: NOVOCURE INC.
General Medicare Issues. H.R.5343/S.1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025.
Client expense: $110,000 · Firm income: —
Matched citations: H.R.5343
Ensuring Patient Access to Critical Breakthrough Products Act of 2025
2025 · fourth_quarter · Firm: NOVOCURE INC.
General Medicare Issues. H.R.5343/S.1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025.
Client expense: $110,000 · Firm income: —
Matched citations: S.1717
Ensuring Patient Access to Critical Breakthrough Products Act
2025 · fourth_quarter · Firm: WILLIAMS AND JENSEN, PLLC
Lobbying for the breakthrough pathway bill (H.R. 5343, S. 1717), CMS reimbursement of medical devices generally, and FDA issues related to medical devices.
Client expense: — · Firm income: —
Matched citations: H.R. 5343
Source: Senate LDA